Recalcitrant nongenital warts

Australian Family Physician

Volumn 40, Issue 1-2, 2011, Pages 40-42

  Leung, Lawrence ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Skin diseases

Indexed keywords

ANTIVIRUS AGENT; DERMATOLOGICAL AGENT; IMMUNOSUPPRESSIVE AGENT; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; CRYOTHERAPY; EVIDENCE BASED MEDICINE; GENERAL PRACTICE; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; LOW LEVEL LASER THERAPY; METHODOLOGY; PHOTOCHEMOTHERAPY; VERRUCA VULGARIS;

ANTI-INFECTIVE AGENTS, LOCAL; ANTIVIRAL AGENTS; CRYOTHERAPY; DERMATOLOGIC AGENTS; EVIDENCE-BASED MEDICINE; GENERAL PRACTICE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRALESIONAL; LASER THERAPY, LOW-LEVEL; PHOTOCHEMOTHERAPY; SALICYLIC ACID; SALICYLIC ACIDS; WARTS;

EID: 79251471399     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Clifton MM, Johnson SM, Roberson PK, et al. Immunotherapy for recalcitrant warts in children using intralesional mumps or candida antigens. Pediatr Dermatol 2003;20:268-71.
2. Handisurya A, Schellenbacher C, Kirnbauer R. Diseases caused by human papillomaviruses (HPV). J Dtsch Dermatol Ges 2009;7:453-66.
3. Sterling JC, Handfield-Jones s, hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol 2001;144:4-11.
4. Gibbs S, Harvey I, sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ 2002;325:461.
5. Salk RS, Grogan KA, chang TJ. Topical 5% 5-fluorouracil cream in the treatment of plantar warts: a prospective, randomized, and controlled clinical study. J Drugs Dermatol 2006;5:418-24.
6. Zschocke I, Hartmann A, Schlobe A, et al. efficacy and benefit of a 5-FU/salicylic acid preparation in the therapy of common and plantar warts - systematic literature review and meta-analysis. J Dtsch Dermatol Ges 2004;2:187-93.
7. Davis MD, Weick JA, Link JS. Response of predominantly recalcitrant cutaneous warts to topical chemotherapy. J Eur Acad Dermatol Venereol 2006;20:232-4.
8. Sachs DL, Kang s, Hammerberg c, et al. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis. Arch Dermatol 2009;145:659-66.
9. Hursthouse MW. A controlled trial on the use of topical 5-fluorouracil on viral warts. Br J Dermatol 1975;92:93-6.
10. Novak N, Yu CF, Bieber T, et al. Toll-like receptor 7 agonists and skin. Drug News Perspect 2008;21:158-65.
11. A Gaspari A, Tyring SK, Rosen T. Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol 2009;8:467-74.
12. Wagstaff AJ, Perry CM. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs 2007;67:2187-210.
13. Micali G, Dall'Oglio F, Nasca MR. An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts. J Dermatolog Treat 2003;14:233-6.
14. Harwood CA, Perrett CM, Brown VL, et al. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals. br J Dermatol 2005;152:122-9.
15. Sollitto RJ, Napoli RC, Gazivoda PL, et al. A perspective study using bleomycin sulfate in the treatment of plantar verrucae. J Foot Surg 1989;28:141-4.
16. Lewis TG, Nydorf ED. Intralesional bleomycin for warts: a review. J Drugs Dermatol 2006;5:499-504.
17. Munn Se, Higgins E, Marshall M, et al. A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br J Dermatol 1996;135:969-71.
18. Manz LA, Pelachyk JM. Bleomycin-lidocaine mixture reduces pain of intralesional injection in the treatment of recalcitrant verrucae. J Am Acad Dermatol 1991;25:524-6.
19. Nayak N, Friedmann PS, Healy e. Case 2. Bleomycin-induced flagellate dermatosis. Clin Exp Dermatol 2003;28:105-6.
20. Abess A, Keel DM, Graham BS. Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris. Arch Dermatol 2003;139:337-9.
21. Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol 2001;137:451-5.
22. Signore RJ. Candida albicans intralesional injection immunotherapy of warts. Cutis 2002;70:185-92.
23. Summers P, Richards-Altmon P, Halder R. Treatment of recalcitrant verruca vulgaris with candida antigen in patient with human immunodeficiency virus. J Drugs Dermatol 2009;8:268-9.
24. Perman M, Sterling JB, Gaspari A. The painful purple digit: an alarming complication of candida albicans antigen treatment of recalcitrant warts. Dermatitis 2005;16:38-40.
25. Horn TD, Johnson SM, Helm RM, et al. Intralesional immunotherapy of warts with mumps, candida, and trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol 2005;141:589-94.
26. Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol 2010;63:1166-70.
27. Gamil H, Elgharib I, Nofal A, Abdelaziz T. Intralesional immunotherapy of plantar warts: report of a new antigen combination. J Am Acad Dermatol 2010;63:40-3.
28. Sebben JE. The status of electrosurgery in dermatologic practice. J Am Acad Dermatol 1988;19:542-9.
29. 2 laser techniques in destruction of verrucae plantaris: discussion of the blister technique, a more complete method of wart ablation. J Foot Surg 1988;27:217-21.
30. Sethuraman G, Richards KA, hiremagalore RN, et al. Effectiveness of pulsed dye laser in the treatment of recalcitrant warts in children. Dermatol Surg 2010;36:58-65.
31. Schellhaas U, Gerber W, Hammes s, et al. Pulsed dye laser treatment is effective in the treatment of recalcitrant viral warts. Dermatol Surg 2008;34:67-72.
32. Togsverd-Bo K, Gluud C, Winkel P, et al. Paring and intense pulsed light versus paring alone for recalcitrant hand and foot warts: a randomized clinical trial with blinded outcome evaluation. Lasers Surg Med 2010;42:179-84.
33. Gooptu C, James MP. Recalcitrant viral warts: results of treatment with the KTP laser. Clin Exp Dermatol 1999;24:60-3.
34. Scheinfeld N, Yu T, Lee J. Verrucous hyperplasia of the great toe: a case and a review of the literature. Dermatol Surg 2004;30(2 Pt 1):215-7.
35. Kelishadi SS, Wirth GA, Evans GR. Recalcitrant verrucous lesion: verrucous hyperplasia or epithelioma cuniculatum (verrucous carcinoma). J Am Podiatr Med Assoc 2006;96:148-53.
36. Dubina M, Goldenberg G. Viralassociated nonmelanoma skin cancers: a review. Am J Dermatopathol 2009;31:561-73.